Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 28Neoplasms 3Neoplasm Metastasis 3Metastatic Castration-Resistant Prostate Cancer (mCRPC) 2Urogenital Neoplasms 1Prostatic Diseases 1Prostate Cancer Metastatic 1Neoplasms, Glandular and Epithelial 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castrate-resistant Prostate Cancer 1Hormone-Refractory Prostate Cancer 1Genital Neoplasms, Male 1Castrate Refractory Metastatic Prostate Cancer (mCRPC) 1Carcinoma 1Adenocarcinoma of the Prostate 1Adenocarcinoma 1

Interventions

sipuleucel-T 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Castrate Refractory Metastatic Prostate Cancer (mCRPC) × sipuleucel-T × Clear all
NCT02232230 2019-01-09

A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T

GenesisCare USA

Completed
20 enrolled
Genitourinary

Castrate Refractory Metastatic Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡